These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3248763)

  • 1. [Epidemiological and clinical studies on strongyloidiasis].
    Mitsueda K
    Fukuoka Igaku Zasshi; 1988 Oct; 79(10):706-22. PubMed ID: 3248763
    [No Abstract]   [Full Text] [Related]  

  • 2. [Strongyloidiasis under immunosuppressive therapy].
    Hanck C; Holzer BR
    Schweiz Med Wochenschr; 1992 Jun; 122(23):899-902. PubMed ID: 1615300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
    Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
    Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies.
    Schaffel R; Nucci M; Portugal R; Castro MB; Ferreira SB; Almeida L; Spector N; Pulcheri W
    Clin Infect Dis; 2000 Sep; 31(3):821-2. PubMed ID: 11017840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for strongyloidiasis hyperinfection and clinical outcomes.
    Asdamongkol N; Pornsuriyasak P; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):875-84. PubMed ID: 17333728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult T-cell leukaemia and strongyloidiasis.
    Kanazawa S; Yamaguchi K; Kinoshita Y; Nomura S
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):209-10. PubMed ID: 18302660
    [No Abstract]   [Full Text] [Related]  

  • 7. Autochthonous strongyloidiasis in Italy: an epidemiological and clinical review of 150 cases.
    Scaglia M; Brustia R; Gatti S; Bernuzzi AM; Strosselli M; Malfitano A; Capelli D
    Bull Soc Pathol Exot Filiales; 1984; 77(3):328-32. PubMed ID: 6488423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of therapeutic effectiveness in strongyloidiasis using mintezol powder and tablet].
    Tikhomirova EP
    Med Parazitol (Mosk); 1982; 51(5):39-41. PubMed ID: 7177049
    [No Abstract]   [Full Text] [Related]  

  • 9. [Strongyloidosis in northwestern Croatia. (Clinical, diagnostic and therapeutic experiences)].
    Bezjak B; Breitenfeld V
    G Mal Infett Parassit; 1969 Jan; 21(1):43-7. PubMed ID: 5771928
    [No Abstract]   [Full Text] [Related]  

  • 10. Some laboratory, epidemiological and clinical features of Strongyloides stercoralis infection in a focus of low endemicity.
    Rawlins SC; Terry SI; Chen WN
    West Indian Med J; 1983 Dec; 32(4):212-8. PubMed ID: 6676988
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodialysis and strongyloidiasis: a presumed cause of eosinophilia able to mask the other].
    Saïd S; Nevez G; Morinière P; Fournier A; Raccurt CP
    Nephrologie; 1999; 20(6):343-6. PubMed ID: 10592937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiabendazole. Clinical trial in treatment of strongyloidiasis in six children.
    Price AE; Brooksaler FS
    Tex Med; 1969 Feb; 65(2):44-7. PubMed ID: 4888599
    [No Abstract]   [Full Text] [Related]  

  • 13. Strongyloidiasis in patients at a comprehensive cancer center in the United States.
    Safdar A; Malathum K; Rodriguez SJ; Husni R; Rolston KV
    Cancer; 2004 Apr; 100(7):1531-6. PubMed ID: 15042689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and treatment characteristics of strongyloidiasis depending on the ABO(H) system of patient blood groups].
    Tikhomirova EP; Prokhorov AF
    Med Parazitol (Mosk); 1983; (5):22-6. PubMed ID: 6227801
    [No Abstract]   [Full Text] [Related]  

  • 15. [New therapeutic regimen with thiabendazole in human strongyloidiasis].
    Chaia G; da Cunha AS
    Rev Inst Med Trop Sao Paulo; 1966; 8(4):173-6. PubMed ID: 5980620
    [No Abstract]   [Full Text] [Related]  

  • 16. [Observations on strongyloidosis in the Western Region of Minas Gerais, Brasil].
    Dias JC
    Rev Inst Med Trop Sao Paulo; 1968; 10(5):305-11. PubMed ID: 5705659
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperinfective strongyloidiasis in the medical ward: review of 27 cases in 5 years.
    Adedayo O; Grell G; Bellot P
    South Med J; 2002 Jul; 95(7):711-6. PubMed ID: 12144076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.
    Gabet AS; Mortreux F; Talarmin A; Plumelle Y; Leclercq I; Leroy A; Gessain A; Clity E; Joubert M; Wattel E
    Oncogene; 2000 Oct; 19(43):4954-60. PubMed ID: 11042682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan.
    Toma H; Sato Y; Shiroma Y; Kobayashi J; Shimabukuro I; Takara M
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):147-51. PubMed ID: 11023084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive arthritis induced by Strongyloides stercoralis.
    Brocq O; Breuil V; Agopian V; Grisot C; Flory P; Bernard-Pomier G; Ziegler G; Euller-Ziegler L
    Rev Rhum Engl Ed; 1996 Mar; 63(3):217-9. PubMed ID: 8731241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.